Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Acquisition entities : Pfizer, inc. save search
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
Published: 2023-12-12 (Crawled : 15:30) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.07%
H: 0.84%
C: -0.14%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 3.27%
H: 0.0%
C: 0.0%
acquisition
Bridgewest Group completes acquisition of sterile injectable manufacturing plant in Western Australia from Pfizer
Published: 2023-04-04 (Crawled : 03:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -1.3%
australia group acquisition
Pfizer Completes Acquisition of Global Blood Therapeutics
Published: 2022-10-05 (Crawled : 16:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.76%
H: 0.57%
C: 0.0%
acquisition blood global therapeutics
Pfizer Completes Acquisition of ReViral
Published: 2022-06-09 (Crawled : 15:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.38%
H: 0.72%
C: -2.79%
acquisition
LianBio’s Partner ReViral Enters into Acquisition Agreement with Pfizer
Published: 2022-04-07 (Crawled : 00:00) - globenewswire.com
LIAN | $4.92 0.41% 0.41% 410K
|
Professional, Scientific, and T...
|
| O: 1.11%
H: 2.0%
C: -7.69%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.56%
H: 1.33%
C: 0.58%
acquisition
Pfizer Completes Acquisition of Arena Pharmaceuticals
Published: 2022-03-11 (Crawled : 20:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
als acquisition
Pfizer Completes Acquisition of Trillium Therapeutics
Published: 2021-11-17 (Crawled : 16:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.95%
H: 0.0%
C: 0.0%
acquisition therapeutics
Trillium Securityholders Approve Acquisition by Pfizer
Published: 2021-10-26 (Crawled : 22:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.39%
H: 0.23%
C: -1.13%
security acquisition approval
Global Cell and Gene Therapy Market Report 2021-2027: Market Opportunities in Drug Approvals and Strong Pipeline & Increasing Number of Mergers and Acquisitions
Published: 2021-03-08 (Crawled : 13:14) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.26%
H: 1.13%
C: -0.38%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.02%
H: 0.89%
C: -0.31%
ORGO | $2.99 0.34% 0.33% 2.5M
|
Finance
|
| O: 1.86%
H: 1.82%
C: -2.21%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.15%
H: 1.81%
C: -0.12%
acquisition gene therapy therapy acquisitions drug merge approval gene therapies
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.